Institute of Biotechnology, University of Helsinki, Viikki Biocenter, Viikinkaari 9B, FIN-00014, Helsinki, Finland.
J Mol Cell Biol. 2011 Dec;3(6):330-40. doi: 10.1093/jmcb/mjr016. Epub 2011 Sep 15.
Mutations in the tumor suppressor gene LKB1 are important in hereditary Peutz-Jeghers syndrome, as well as in sporadic cancers including lung and cervical cancer. LKB1 is a kinase-activating kinase, and a number of LKB1-dependent phosphorylation cascades regulate fundamental cellular and organismal processes in at least metabolism, polarity, cytoskeleton organization, and proliferation. Conditional targeting approaches are beginning to demonstrate the relevance and specificity of these signaling pathways in development and homeostasis of multiple organs. More than one of the pathways also appear to contribute to tumor growth following Lkb1 deficiencies based on a number of mouse tumor models. Lkb1-dependent activation of AMPK and subsequent inactivation of mammalian target of rapamycin signaling are implicated in several of the models, and other less well characterized pathways are also involved. Conditional targeting studies of Lkb1 also point an important role of LKB1 in epithelial-mesenchymal interactions, significantly expanding knowledge on the relevance of LKB1 in human disease.
肿瘤抑制基因 LKB1 的突变在遗传性 Peutz-Jeghers 综合征以及包括肺癌和宫颈癌在内的散发性癌症中很重要。LKB1 是一种激酶激活激酶,许多依赖于 LKB1 的磷酸化级联反应调节至少在代谢、极性、细胞骨架组织和增殖方面的基本细胞和机体过程。条件性靶向方法开始证明这些信号通路在多个器官的发育和稳态中的相关性和特异性。基于许多小鼠肿瘤模型,Lkb1 缺乏后,至少有一条通路似乎也有助于肿瘤生长。Lkb1 依赖性 AMPK 的激活以及随后 mTOR 信号的失活与几种模型有关,其他特征不那么明显的通路也参与其中。Lkb1 的条件性靶向研究也指出 LKB1 在上皮-间充质相互作用中的重要作用,显著扩展了 LKB1 在人类疾病中的相关性的知识。